Hyponatremia as an independent prognostic factor in patients with terminal cancer

Tolvaptan, a Selective Oral Vasopressin V ₂ -Receptor Antagonist, for Hyponatremia

Robert W. Schrier, Mihai Gheorghiade, Tomás Berl et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Palliative Performance Scale (PPS): A New Tool

Fern Anderson, George Downing, J. Hill et al. · Journal of Palliative Care · 1996 · 1K citations

Nursing, Palliative Nursing, Hospice Care +12

Mortality after Hospitalization with Mild, Moderate, and Severe Hyponatremia

Sushrut S. Waikar, David B. Mount, Gary C. Curhan · The American Journal of Medicine · 2009 · 725 citations · Full text

Medicine, Internal Medicine, Hospital Medicine +4

Impact of Hospital-Associated Hyponatremia on Selected Outcomes

Ron Wald · Archives of Internal Medicine · 2010 · 529 citations

Medicine, Internal Medicine, Clinical Biochemistry +13

Vasopressin V ₂ -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure

Mihai Gheorghiade, Imran Khan Niazi, John Ouyang et al. · Circulation · 2003 · 430 citations

Medicine, Pharmacology, Pharmacotherapy +17